Dr. Tanya Kaur Greywal, MD

Dr. Greywal practices at UW Medical Center - Montlake in Seattle, Washington, part of University of Washington.

Dr. Greywal's NPI, 1043664600, was assigned on April 20, 2016. Dr. Greywal holds Washington license MD61170622.

Dr. Greywal's primary practice is UW Medical Center - Montlake, at 1959 NE Pacific St Box 356151, Seattle, WA 98195 in King County. The practice phone is (206) 598-3300.

Dr. Greywal's primary practice is UW Medical Center - Montlake in Seattle, Washington, part of University of Washington. The medical group on file is UW Physicians. Dmand AI also links Dr. Greywal to 1 more hospital, 1 hospital outpatient department and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Greywal practices, 3 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Greywal's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Greywal is licensed in Washington.

CMS data shows 1,092 Medicare services from Dr. Greywal across 11 procedure codes in 2024, for 277 Medicare patients. Medicare paid $41,740 for them. Every service was in an office.

CMS counts 277 Medicare patients who saw Dr. Greywal in 2024. The largest group is 65 to 74, with 119 patients. 60% of them have high blood pressure, and 58% have high cholesterol. 8% are also on Medicaid. Their average risk score is 1.25, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Greywal's median patient age at 54, with 59% women.

In 2024, Dr. Greywal wrote 530 Medicare Part D claims for 193 patients. 87% of them were for generic drugs. CMS names the drug for 389 of them, across 11 drugs with 11 or more claims each, at $59,316 in total drug cost. In 2023, CMS named 354 claims across 11 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Greywal for performance year 2024, reported through an alternative payment model (APM). Dr. Greywal accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Greywal as offering telehealth. CMS counts 242 procedures of removal of skin lesions by Dr. Greywal, more than 80% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 21 papers to Dr. Greywal, published from 2015 to 2024. 2015 was the busiest year, with 5. The most frequent topics are Acne Vulgaris, Administration, Cutaneous and Anti-Bacterial Agents. Dr. Greywal has published most often in Pediatr Dermatol. Dr. Greywal's most frequent co-authors are Philip R. Cohen, MD, Sheila Fallon Friedlander, MD and Lawrence F. Eichenfield, MD.

CMS Open Payments shows 2 general payments to Dr. Greywal from 2 drug and device companies from 2018 to 2020. Food and beverage make up the largest share, 100% of the total. Regeneron Pharmaceuticals, Inc. paid the most, $124.